NXT BLD 2026. With design automation, AI, and data-driven approaches set to reshape AEC, NXT BLD has never felt more important ...
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果